T1	Participants 21 63	cryotherapy for retinopathy of prematurity
T2	Participants 163 207	preliminary 3-month outcome of a multicenter
T3	Participants 228 290	cryotherapy for treatment of retinopathy of prematurity (ROP).
T4	Participants 396 516	threshold disease (defined as five or more contiguous or eight cumulative 30 degree sectors [clock hours] of stage 3 ROP
T5	Participants 616 692	retinal detachment, retinal fold involving the macula, or retrolental tissue
T6	Participants 711 740	172 infants had been examined
